Blood Group Genotyping for Sickle Cell and Thalassaemia

A Contract Award Notice
by NHS ENGLAND

Source: Find a Tender
Type: Contract ()
Duration: not specified
Value: £141K

Sector: MISCELLANEOUS
Published: 05 Dec 2025
Delivery: not specified
Deadline: n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

NHS England London

1 supplier

NHSBT Bristol

Description

Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping

Award Detail

1	NHSBT (Bristol) Blood Group Genotyping for Sickle Cell and Thalassaemia Reference: 1 Value: £140,671

CPV Codes

None found

Legal Justification

Due to an absence of competition for technical reasons. Para 6, Schedule 5 of PA 2023 utilised. NHSBT have been verified as the only organisation in England that could deliver this service for the planned typing of patients with Sickle Cell Disease blood patients, thalassemia and rare inherited anaemia